Because our purpose is delivering better patient outcomes
It begins with a passion for innovation. For people. For making a difference. At Lantheus, we Find, Fight and Follow® disease to improve outcomes and lives.
We are the leading radiopharmaceutical-focused company with proven expertise in developing, manufacturing and commercializing cutting-edge radiodiagnostics. As we build on this strong foundation, we are boldly expanding into radiotherapeutics–driven by our commitment to innovation, perseverance and partnerships.
Our heritage
For 70 years, Lantheus has been advancing patient care by learning, adapting and making advancements across the healthcare spectrum. We’ve been an instrumental pioneer in the field of medical imaging and today, we’re reaching further still with novel radiotherapeutics—continuing to forge ahead with meaningful solutions to complex challenges, always knowing that someone’s health is in our hands.
Our broad portfolio features:
Radiopharmaceutical therapies and diagnostics that Find, Fight and Follow® cancer
Precision diagnostics that find and follow diseases in nononcologic conditions
Strategic partnerships that empower precision medicine through the use of biomarkers and digital solutions
Our history
Lantheus has a rich history of transformative mergers, acquisitions and innovative product launches. Explore our evolution from our founding as New England Nuclear in 1956 to today.
